Vitalities Lab, Centre for Social Research in Health and Social Policy Research Centre, Goodsell Building, University of New South Wales (UNSW), Sydney 2052, Australia.
Health Promot Int. 2023 Feb 1;38(1). doi: 10.1093/heapro/daac192.
Since the outbreak of COVID-19 globally, a range of vaccines has been developed and delivered to reduce viral transmission and prevent COVID cases. This article reports findings from a qualitative research project involving telephone interviews with a diverse group of 40 adult Australians about their experiences of the COVID crisis. Interviews were conducted in late 2021 when Australians were dealing with the Delta variant outbreak and following a major effort on the part of government authorities to improve COVID-19 vaccination supplies and take-up. Responses to a question about COVID vaccines revealed that attitudes to and acceptance of COVID vaccines among this group were overwhelmingly positive. All participants had received at least one vaccine dose and the majority expressed views in support of mass vaccination against COVID. People who were hesitant or cautious about accepting COVID vaccination referred to the vaccines' novelty and potential side effects. While many people were aware of debates about vaccine safety in the news media, trust in science and medical advice about COVID vaccines was strong. Participants wanted to protect themselves and others by accepting the recommended doses. Participants' locale was a major factor in shaping experiences and stances on vaccines. The setting of government targets and mandates for vaccination was a key motivating factor. The goal of 'getting back to normal' was expressed as another reason for accepting vaccination, particularly for those living in areas that had been badly affected by high COVID cases and prolonged lockdowns.
自全球 COVID-19 爆发以来,已经开发并提供了多种疫苗,以减少病毒传播并预防 COVID 病例。本文报告了一项定性研究项目的结果,该项目涉及对 40 名不同的成年澳大利亚人的电话访谈,了解他们对 COVID 危机的体验。访谈于 2021 年末进行,当时澳大利亚人正在应对 Delta 变异株的爆发,并且政府当局在努力提高 COVID-19 疫苗供应和接种率方面取得了重大进展。对一个关于 COVID 疫苗的问题的回答显示,该群体对 COVID 疫苗的态度和接受程度是压倒性的积极。所有参与者都至少接种了一剂疫苗,大多数人表示支持大规模接种 COVID 疫苗。对接受 COVID 疫苗犹豫不决或谨慎的人提到了疫苗的新颖性和潜在的副作用。虽然许多人意识到新闻媒体上有关疫苗安全性的争论,但对 COVID 疫苗的科学和医学建议的信任度很强。参与者希望通过接受推荐的剂量来保护自己和他人。参与者的所在地是塑造他们对疫苗的体验和立场的主要因素。政府设定疫苗接种目标和规定是一个关键的激励因素。“恢复正常”是另一个接受疫苗接种的原因,特别是对于那些生活在 COVID 病例高发和长期封锁地区的人。